We test, compare, and explain the leading telehealth weight-loss providers — including Oak, Medvi, TrimRx, DirectMeds, Gala, and System Labs — so you can choose the right program without sifting through marketing copy.
Each review is structured the same way — verdict, pricing, qualification, medications, safety, and customer feedback — so you can compare apples to apples.
$133/mo semaglutide, $199/mo tirzepatide, no subscription, LegitScript certified. Full breakdown of pricing, eligibility, and who Oak is really for.
$179 first / $299 ongoing semaglutide. Unlimited provider messaging, oral GLP-1 tablets, and branded Wegovy/Ozempic access on the same platform.
$179 promo / $349 standard semaglutide. Guaranteed flat-rate pricing as your dose escalates — unique in the 2026 category. HSA/FSA accepted.
$179 sema injection, $249 sublingual oral, $399 tirz. The only major provider with licensed-nurse support included and a sublingual oral GLP-1 option.
$179/month flat across all doses. Women-focused care, 50,000+ patients treated, dedicated mobile app. Trade-off: yearly subscription required.
$179/month flat for compounded GLP-1/GIP (tirzepatide-class). Pause anytime — no annual lock-in. 2-day temp-controlled shipping, named medical advisor.
When you're weighing two providers side-by-side, these matchups break down pricing, medications offered, qualification thresholds, and member experience.
Pricing, medications, medical oversight, and cancellation policy compared point-for-point.
Which program delivers better value on compounded semaglutide and tirzepatide month-to-month.
If you're looking specifically for tirzepatide access, here's how these two programs stack up.
Quick, direct answers to the questions readers ask us most.
One short email a month with new reviews, pricing changes, and important program updates. No fluff. Unsubscribe anytime.
Subscribe